PIA
SNNA

Piedmont Investment Advisors’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Piedmont Investment Advisors’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-268
Closed -$4K – 2783
2018
Q2 		$4K Buy
+268
New +$4.55K ﹤0.01% 2326

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Piedmont Investment Advisors's SNNA Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2018, closing a stake of 268 shares — an estimated $4K sold.

Piedmont Investment Advisors first reported a position in SNNA in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 54 funds tracked by Wall St. Rank hold SNNA as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 268 Sienna Biopharmaceuticals, Inc. shares in Q3 2018, an estimated $4K.
  • Piedmont Investment Advisors first reported a position in Sienna Biopharmaceuticals, Inc. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Sienna Biopharmaceuticals, Inc. position peaked at $4K in Q2 2018.
  • 54 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.